Medical Facilities Corporation (DR:CA) Stock Forecast
Show ratings and price targets of :
Alert
Its only available to paid users.
CAD 12.00
(+8.99%)
Based on the Medical Facilities Corporation stock forecast from 1 analysts, the average analyst target price for Medical Facilities Corporation is CAD 12.00 over the next 12 months. Medical Facilities Corporation’s average analyst rating is Hold . Stock Target Advisor’s own stock analysis of Medical Facilities Corporation is Bullish , which is based on 11 positive signals and 4 negative signals. At the last closing, Medical Facilities Corporation’s stock price was CAD 11.01. Medical Facilities Corporation’s stock price has changed by +0.46% over the past week, +8.05% over the past month and +37.28% over the last year.
No recent analyst target price found for Medical Facilities Corporation
No recent average analyst rating found for Medical Facilities Corporation
Company Overview Medical Facilities Corporation
Medical Facilities Corporation, through its subsidiaries, owns and operates specialty hospitals and ambulatory surgery center in the United States. The company's specialty hospital offers non-emergency surgical, imaging, diagnostic, and pain management procedures, as well as other ancillary services, such as primary and urgent care; and ambulatory surgery centers offers scheduled outpatient surgical procedures. Medical Facilities Corporation was incorporated in 2004 and is headquartered in Toronto, Canada. Address: 4576 Yonge Street, Toronto, ON, Canada, M2N 6N4 Read Less
Medical Facilities Corporation, through its subsidiaries, owns and operates specialty hospitals and ambulatory surgery center in the United States. The company's specialty hospital offers non-emergency surgical, imaging, diagnostic, and pain management procedures, as well as othe...Read More
Frequently Asked Questions About Medical Facilities Corporation (DR:CA) Stock
Based on ratings from 1 analysts Medical Facilities Corporation's stock is Hold . Stock Target Advisor's fundamental analysis is Bullish . The stock has buy, sell and 1 hold ratings.
DR:CA stock's dividend yield is 2.89%.
Our analysis grades DR:CA stock's dividend yield at F. This means that DR:CA stock's dividend yield is above 33% of the stocks in the Medical Care Facilities sector in the TSX exchange.
Based on this DR:CA may be a poor dividend stock for its sector.
Based on targets from 1 analysts, the average taret price for DR:CA is CAD 12.00 over the next 12 months. The maximum analyst target price is CAD 12 while the minimum anlayst target price is CAD 12.
DR:CA stock's Price/Earning ratio is 11.16.
Our analysis grades DR:CA stock's Price / Earning ratio at A+. This means that DR:CA stock's Price/Earning ratio is above 0% of the stocks in the Medical Care Facilities sector in the TSX exchange.
Based on this DR:CA may be undervalued for its sector.
The last closing price of DR:CA's stock was CAD 11.01.
The most recent market capitalization for DR:CA is CAD 0.28B.
Based on targets from 1 analysts, the average taret price for DR:CA is projected at CAD 12.00 over the next 12 months.
This means that DR:CA's stock price may go up by +8.99% over the next 12 months.
We can't find any ETFs which contains Medical Facilities Corporation's stock.
As per our most recent records Medical Facilities Corporation has 0 Employees.
Medical Facilities Corporation's registered address is 4576 Yonge Street, Toronto, ON, Canada, M2N 6N4.
You can get more information about it from Medical Facilities Corporation's website at https://www.medicalfacilitiescorp.ca.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced on cashflow basis
The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
Underpriced on free cash flow basis
The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
High dividend returns
The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for DR:CA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
